BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36874959)

  • 1. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
    Kavuru V; Senger RS; Robertson JL; Choudhury D
    PeerJ; 2023; 11():e14879. PubMed ID: 36874959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
    Musolino M; Greco M; D'Agostino M; Tripodi L; Misiti R; Dragone F; Cianfrone P; Zicarelli M; Foti DP; Andreucci M; Bolignano D; Coppolino G
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541089
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
    Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS
    PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
    Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
    Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
    Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
    BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the relationship between lipoprotein (a) and diabetic kidney disease.
    Wang A; Zhang S; Li Y; Zhu F; Xie B
    J Diabetes Complications; 2023 Jan; 37(1):108378. PubMed ID: 36549039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
    Li H; Shen Y; Yu Z; Huang Y; He T; Xiao T; Li Y; Xiong J; Zhao J
    Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
    Zhou Y; Zhang Y; Chen J; Wang T; Li H; Wu F; Shang J; Zhao Z
    Front Physiol; 2023; 14():1173982. PubMed ID: 37929213
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary glycated uromodulin in diabetic kidney disease.
    Chang CC; Chen CY; Huang CH; Wu CL; Wu HM; Chiu PF; Kor CT; Chen TH; Chang GD; Kuo CC; Wen HC; Huang CY; Chang CH
    Clin Sci (Lond); 2017 Aug; 131(15):1815-1829. PubMed ID: 28592554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
    Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L
    Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease.
    Wang Q; Dong ZY; Zhang WG; Liu XM; Qu YL; Duan SW; Huang MJ; Zhou JH; Chen P; Zhu HY; Zhang L; Sun XF; Cai GY; Chen XM
    Clin Chim Acta; 2020 Mar; 502():222-226. PubMed ID: 31730818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.
    Mccafferty K; Caplin B; Knight S; Hockings P; Wheeler D; Fan SL; Hulthe J; Kleta R; Ashman N; Papastefanou V; Mehta H; Salama A; Hadzovic S; Chowdhury TA; Jarl L; Unwin R; Challis B; Sundgren AK; Yaqoob MM
    BMJ Open; 2020 Sep; 10(9):e033923. PubMed ID: 32912939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular filtration Rate, urine Albumin/ creatinine ratio and current perception threshold in patients with diabetic kidney disease.
    Pi CX; Gui TJ; He QD; Yin F; Cai RJ; Wang Y; Xue QX; Tian XK; Wang T; Zhe XW
    Diabetes Res Clin Pract; 2022 Jul; 189():109934. PubMed ID: 35640744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.